Literature DB >> 10966737

Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one.

D F Covey1, M Han, A S Kumar, M A de La Cruz, E S Meadows, Y Hu, A Tonnies, D Nathan, M Coleman, A Benz, A S Evers, C F Zorumski, S Mennerick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10966737     DOI： 10.1021/jm0002477

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Authors:  Casey J Fox; Peter S Hammerman; Ryan M Cinalli; Stephen R Master; Lewis A Chodosh; Craig B Thompson
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

2.  17beta-Nitro-5alpha-androstan-3alpha-ol and its 3beta-methyl derivative: neurosteroid analogs with potent anticonvulsant and anxiolytic activities.

Authors:  Scott P Runyon; Matthew Orr; Hernán A Navarro; John A Kepler; Michael A Rogawski; Rafal M Kaminski; C Edgar Cook
Journal:  Eur J Pharmacol       Date:  2009-07-02       Impact factor: 4.432

3.  Neurosteroids and GABA-A Receptor Function.

Authors:  Mingde Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-04       Impact factor: 5.555

4.  Reagent-controlled regiodivergent ring expansions of steroids.

Authors:  Manwika Charaschanya; Jeffrey Aubé
Journal:  Nat Commun       Date:  2018-03-05       Impact factor: 14.919

5.  Crystal structure of (20S)-21-[4-(2-hy-droxy-propan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methyl-pent-yl)-5-pregnen-3β-ol with an unknown solvate.

Authors:  Hugo Santalla; Saray Argibay
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-03-06

6.  L-3,3',5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors.

Authors:  Steven X Moffett; Eric A Klein; Grace Brannigan; Joseph V Martin
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.